Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charita M Christou

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biology|May 17, 2014
BRCA1 and Its Network of Interacting PartnersCharita M Christou, Kyriacos Kyriacou
Protein Expression and Purification|May 18, 2011
Expression, purification and crystallization of the human UL16-binding protein ULBP1Aleksandra A Watson, Charita M Christou, Christopher A O'Callaghan
Plos One|April 4, 2014
The BRCA1 variant p.Ser36Tyr abrogates BRCA1 protein function and potentially confers a moderate risk of breast cancerCharita M Christou, Andreas Hadjisavvas, Maria Kyratzi, et al.
Plos One|October 23, 2010
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivoOlivier Morteau, Samkeliso Blundell, Aron Chakera, et al.
Biochemistry|October 15, 2009
The platelet receptor CLEC-2 is active as a dimerAleksandra A Watson, Charita M Christou, John R James, et al.
The Biochemical Journal|January 25, 2008
Renal cells activate the platelet receptor CLEC-2 through podoplaninCharita M Christou, Andrew C Pearce, Aleksandra A Watson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biology|May 17, 2014
BRCA1 and Its Network of Interacting PartnersCharita M Christou, Kyriacos Kyriacou
Protein Expression and Purification|May 18, 2011
Expression, purification and crystallization of the human UL16-binding protein ULBP1Aleksandra A Watson, Charita M Christou, Christopher A O'Callaghan
Plos One|April 4, 2014
The BRCA1 variant p.Ser36Tyr abrogates BRCA1 protein function and potentially confers a moderate risk of breast cancerCharita M Christou, Andreas Hadjisavvas, Maria Kyratzi, et al.
Plos One|October 23, 2010
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivoOlivier Morteau, Samkeliso Blundell, Aron Chakera, et al.
Biochemistry|October 15, 2009
The platelet receptor CLEC-2 is active as a dimerAleksandra A Watson, Charita M Christou, John R James, et al.
The Biochemical Journal|January 25, 2008
Renal cells activate the platelet receptor CLEC-2 through podoplaninCharita M Christou, Andrew C Pearce, Aleksandra A Watson, et al.
Pageof 1